These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 38641466)
1. Adolescent-onset epilepsy and deterioration associated with CAD deficiency: A case report. Silva S; Rosas M; Guerra B; Muñoz M; Fujita A; Sakamoto M; Matsumoto N Brain Dev; 2024 Aug; 46(7):250-253. PubMed ID: 38641466 [TBL] [Abstract][Full Text] [Related]
3. Triacetyluridine treats epileptic encephalopathy from CAD mutations: a case report and review. Frederick A; Sherer K; Nguyen L; Ali S; Garg A; Haas R; Sahagian M; Bui J Ann Clin Transl Neurol; 2021 Jan; 8(1):284-287. PubMed ID: 33249780 [TBL] [Abstract][Full Text] [Related]
4. CAD gene and early infantile epileptic encephalopathy-50; three Iranian deceased patients and a novel mutation: case report. Yarahmadi SG; Morovvati S BMC Pediatr; 2022 Mar; 22(1):125. PubMed ID: 35277149 [TBL] [Abstract][Full Text] [Related]
5. Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy. Del Caño-Ochoa F; Ng BG; Abedalthagafi M; Almannai M; Cohn RD; Costain G; Elpeleg O; Houlden H; Karimiani EG; Liu P; Manzini MC; Maroofian R; Muriello M; Al-Otaibi A; Patel H; Shimon E; Sutton VR; Toosi MB; Wolfe LA; Rosenfeld JA; Freeze HH; Ramón-Maiques S Genet Med; 2020 Oct; 22(10):1598-1605. PubMed ID: 32461667 [TBL] [Abstract][Full Text] [Related]
6. Uridine-responsive epileptic encephalopathy due to inherited variants in CAD: A Tale of Two Siblings. McGraw CM; Mahida S; Jayakar P; Koh HY; Taylor A; Resnick T; Rodan L; Schwartz MA; Ejaz A; Sankaran VG; Berry G; Poduri A Ann Clin Transl Neurol; 2021 Mar; 8(3):716-722. PubMed ID: 33497533 [TBL] [Abstract][Full Text] [Related]
7. CAD Deficiency-Another Treatable Early Infantile Epileptic Encephalopathy. Kamate M; Patil S Pediatr Neurol; 2020 Sep; 110():97-98. PubMed ID: 32654958 [No Abstract] [Full Text] [Related]
8. Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors. Ng BG; Wolfe LA; Ichikawa M; Markello T; He M; Tifft CJ; Gahl WA; Freeze HH Hum Mol Genet; 2015 Jun; 24(11):3050-7. PubMed ID: 25678555 [TBL] [Abstract][Full Text] [Related]
9. Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation. Rymen D; Lindhout M; Spanou M; Ashrafzadeh F; Benkel I; Betzler C; Coubes C; Hartmann H; Kaplan JD; Ballhausen D; Koch J; Lotte J; Mohammadi MH; Rohrbach M; Dinopoulos A; Wermuth M; Willis D; Brugger K; Wevers RA; Boltshauser E; Bierau J; Mayr JA; Wortmann SB Genet Med; 2020 Oct; 22(10):1589-1597. PubMed ID: 32820246 [TBL] [Abstract][Full Text] [Related]
10. Novel CAD gene mutations in a boy with developmental and epileptic encephalopathy 50 with dramatic response to uridine therapy: a case report and a review of the literature. Duan L; Ye L; Yin R; Sun Y; Yu W; Zhang Y; Zhong H; Bao X; Tian X BMC Pediatr; 2024 Mar; 24(1):160. PubMed ID: 38454370 [TBL] [Abstract][Full Text] [Related]
11. A Patient With CAD Deficiency Responsive to Uridine and Literature Review. Zhou L; Xu H; Wang T; Wu Y Front Neurol; 2020; 11():64. PubMed ID: 32117025 [TBL] [Abstract][Full Text] [Related]
12. Rheb protein binds CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase) protein in a GTP- and effector domain-dependent manner and influences its cellular localization and carbamoyl-phosphate synthetase (CPSase) activity. Sato T; Akasu H; Shimono W; Matsu C; Fujiwara Y; Shibagaki Y; Heard JJ; Tamanoi F; Hattori S J Biol Chem; 2015 Jan; 290(2):1096-105. PubMed ID: 25422319 [TBL] [Abstract][Full Text] [Related]
13. Beyond genetics: Deciphering the impact of missense variants in CAD deficiency. Del Caño-Ochoa F; Ng BG; Rubio-Del-Campo A; Mahajan S; Wilson MP; Vilar M; Rymen D; Sánchez-Pintos P; Kenny J; Ley Martos M; Campos T; Wortmann SB; Freeze HH; Ramón-Maiques S J Inherit Metab Dis; 2023 Nov; 46(6):1170-1185. PubMed ID: 37540500 [TBL] [Abstract][Full Text] [Related]
14. Immunochemical analysis of the domain structure of CAD, the multifunctional protein that initiates pyrimidine biosynthesis in mammalian cells. Grayson DR; Lee L; Evans DR J Biol Chem; 1985 Dec; 260(29):15840-9. PubMed ID: 2866187 [TBL] [Abstract][Full Text] [Related]
15. Structural Insight into the Core of CAD, the Multifunctional Protein Leading De Novo Pyrimidine Biosynthesis. Moreno-Morcillo M; Grande-García A; Ruiz-Ramos A; Del Caño-Ochoa F; Boskovic J; Ramón-Maiques S Structure; 2017 Jun; 25(6):912-923.e5. PubMed ID: 28552578 [TBL] [Abstract][Full Text] [Related]
16. CAD, A Multienzymatic Protein at the Head of de Novo Pyrimidine Biosynthesis. Del Caño-Ochoa F; Moreno-Morcillo M; Ramón-Maiques S Subcell Biochem; 2019; 93():505-538. PubMed ID: 31939163 [TBL] [Abstract][Full Text] [Related]
17. Pyrimidine Biosynthetic Enzyme CAD: Its Function, Regulation, and Diagnostic Potential. Li G; Li D; Wang T; He S Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638594 [TBL] [Abstract][Full Text] [Related]
18. Nucleotide sequence and tissue-specific expression of the multifunctional protein carbamoyl-phosphate synthetase-aspartate transcarbamoylase-dihydroorotase (CAD) mRNA in Squalus acanthias. Hong J; Salo WL; Anderson PM J Biol Chem; 1995 Jun; 270(23):14130-9. PubMed ID: 7775474 [TBL] [Abstract][Full Text] [Related]
19. Getting CAD in shape: the atomic structure of human dihydroorotase domain. Hermoso JA Structure; 2014 Feb; 22(2):179-81. PubMed ID: 24507779 [TBL] [Abstract][Full Text] [Related]
20. carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad) regulates Notch signaling and vascular development in zebrafish. Coxam B; Neyt C; Grassini DR; Le Guen L; Smith KA; Schulte-Merker S; Hogan BM Dev Dyn; 2015 Jan; 244(1):1-9. PubMed ID: 25294789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]